ARMATA PHARMACEUTICALS, INC. (ARMP) Free cash flow 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$26.3MFY2025 · since FY2016: -$10.9M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | +33.3% |
| FY2024 | -$39.4M | +29.0% |
| FY2023 | -$55.6M | -60.2% |
| FY2022 | -$34.7M | -39.4% |
| FY2021 | -$24.9M | -30.3% |
| FY2020 | -$19.1M | -20.8% |
| FY2019 | -$15.8M | -37.4% |
| FY2018 | -$11.5M | -24.3% |
| FY2017 | -$9.3M | +15.0% |
| FY2016 | -$10.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARMP financial trends
ARMP RevenueARMP Net incomeARMP Net marginARMP Gross profitARMP Gross marginARMP Operating incomeARMP Operating marginARMP Operating cash flowARMP Capital expendituresARMP Return on equityARMP Stock buybacksARMP Dividends paidARMP Total assetsARMP Total liabilitiesARMP Shareholders’ equityARMP overview →